Novel aryl carbamate derivatives of metronidazole as potential antiamoebic agents
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hayat, Faisal | - |
dc.contributor.author | Wahedi, Hussain Mustatab | - |
dc.contributor.author | Park, Seonghyeok | - |
dc.contributor.author | Tariq, Saba | - |
dc.contributor.author | Azam, Amir | - |
dc.contributor.author | Shin, Dongyun | - |
dc.date.available | 2020-02-28T03:42:14Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2016-01 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/8706 | - |
dc.description.abstract | A series of novel aryl carbamate derivatives of metronidazole (MNZ) were designed, synthesized, and screened for antiamoebic activity. As compared to MNZ, most of the derivatives exhibited moderate to excellent activity against the HM1:IMSS strain of Entamoeba histolytica. Compounds 7, 14, 16, 19, and 21 exhibited the most promising antiamoebic activity with IC50 values of 0.24, 0.08, 0.26, 0.26, and 0.15 mu M, respectively, compared to that of MNZ (1.78 mu M). Moreover, from the toxicological studies of these compounds on human melanocytes, the melan-a cell line revealed that the potent compounds are nontoxic at concentrations ranging from 2.5 to 50 mu M. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | PHARMACEUTICAL SOC KOREA | - |
dc.relation.isPartOf | ARCHIVES OF PHARMACAL RESEARCH | - |
dc.subject | ENTAMOEBA-HISTOLYTICA | - |
dc.subject | INHIBITORS | - |
dc.subject | RESISTANCE | - |
dc.subject | PRODRUGS | - |
dc.title | Novel aryl carbamate derivatives of metronidazole as potential antiamoebic agents | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000368200100004 | - |
dc.identifier.doi | 10.1007/s12272-015-0686-4 | - |
dc.identifier.bibliographicCitation | ARCHIVES OF PHARMACAL RESEARCH, v.39, no.1, pp.33 - 42 | - |
dc.identifier.kciid | ART002075386 | - |
dc.identifier.scopusid | 2-s2.0-84954232169 | - |
dc.citation.endPage | 42 | - |
dc.citation.startPage | 33 | - |
dc.citation.title | ARCHIVES OF PHARMACAL RESEARCH | - |
dc.citation.volume | 39 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Hayat, Faisal | - |
dc.contributor.affiliatedAuthor | Wahedi, Hussain Mustatab | - |
dc.contributor.affiliatedAuthor | Park, Seonghyeok | - |
dc.contributor.affiliatedAuthor | Shin, Dongyun | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Metronidazole | - |
dc.subject.keywordAuthor | Aryl carbamate | - |
dc.subject.keywordAuthor | Structure-activity relationship | - |
dc.subject.keywordAuthor | Entamoeba histolytica | - |
dc.subject.keywordAuthor | Antiamoebic | - |
dc.subject.keywordPlus | ENTAMOEBA-HISTOLYTICA | - |
dc.subject.keywordPlus | INHIBITORS | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordPlus | PRODRUGS | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.